| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
119 Accurate anatomic reference points specification and implant positioning deviations in cervix MDR brachytherapy using the PLATO TPS
|
|
|
2005
|
75 |
S1 |
p. S48-
1 p.
|
artikel
|
| 2 |
134 Adjuvant HDR brachytherapy in patients with recurrent advanced head and neck squamous cell carcinoma (SCC)
|
|
|
2005
|
75 |
S1 |
p. S53-
1 p.
|
artikel
|
| 3 |
32 Advantage of high dose rate (HDR) boost brachytherapy in the treatment of cancer of the base of the tongue
|
|
|
2005
|
75 |
S1 |
p. S13-
1 p.
|
artikel
|
| 4 |
42 Anal implants, using a loop technique in 40 patients
|
|
|
2005
|
75 |
S1 |
p. S19-
1 p.
|
artikel
|
| 5 |
116 An alternative method using C-arm in reconstruction of Fletcher-Suit-Delclos applicator
|
|
|
2005
|
75 |
S1 |
p. S47-
1 p.
|
artikel
|
| 6 |
148 Analysis of early complications and treatment tolerance in patients treated with pulsed-dose-rate brachytherapy
|
|
|
2005
|
75 |
S1 |
p. S56-
1 p.
|
artikel
|
| 7 |
64 Analysis of pretreatment factors predictive of urinary morbidity following permanent prostate brachytherapy (PPB) including cystoscopic findings and uroflowmetry
|
|
|
2005
|
75 |
S1 |
p. S28-
1 p.
|
artikel
|
| 8 |
72 An assessment of applicator and soft tissue movement during image-guided HDR intracavitary brachytherapy for cervical cancer
|
|
|
2005
|
75 |
S1 |
p. S32-
1 p.
|
artikel
|
| 9 |
88 A new set of needles and matrixes for HDR brachytherapy of prostate cancer
|
|
|
2005
|
75 |
S1 |
p. S37-S38
2 p.
|
artikel
|
| 10 |
53 Assessment of the intrinsic accuracy of CT- and MR-based postimplant seed reconstruction with a dedicated prostate phantom
|
|
|
2005
|
75 |
S1 |
p. S24-
1 p.
|
artikel
|
| 11 |
47 A survey of brachytherapy accidents in Japan
|
|
|
2005
|
75 |
S1 |
p. S21-
1 p.
|
artikel
|
| 12 |
Author index
|
|
|
2005
|
75 |
S1 |
p. S61-S63
3 p.
|
artikel
|
| 13 |
14 Better acute and late toxicity profile including erectile dysfunction (ED) with HDR brachytherapy compared with Pd103 seeds implant based on clinical data and Quality of Life (QoL) assessment in early prostate cancer patients
|
|
|
2005
|
75 |
S1 |
p. S6-
1 p.
|
artikel
|
| 14 |
11 Boost treatment for intermediate and high risk prostate cancer: low dose rate vs. high dose rate
|
|
|
2005
|
75 |
S1 |
p. S5-
1 p.
|
artikel
|
| 15 |
33 Brachytherapy for squamous cell carcinoma of the nasal vestibule — Columella
|
|
|
2005
|
75 |
S1 |
p. S13-S14
2 p.
|
artikel
|
| 16 |
38 Brachytherapy in anal canal and rectal tumours
|
|
|
2005
|
75 |
S1 |
p. S17-
1 p.
|
artikel
|
| 17 |
39 Brachytherapy in anal cancer
|
|
|
2005
|
75 |
S1 |
p. S17-
1 p.
|
artikel
|
| 18 |
40 Brachytherapy in rectal cancer (curative intent) clatterbridge experience
|
|
|
2005
|
75 |
S1 |
p. S17-S18
2 p.
|
artikel
|
| 19 |
94 Catheter displacement and its impact on dose distribution with self-fixating catheters for PDR prostate brachytherapy
|
|
|
2005
|
75 |
S1 |
p. S39-S40
2 p.
|
artikel
|
| 20 |
96 Changes of dose distribution in the first month after permanent interstitial brachytherapy for prostate cancer
|
|
|
2005
|
75 |
S1 |
p. S40-
1 p.
|
artikel
|
| 21 |
67 Class solution for inversely planned permanent prostate implants to mimic an experienced dosimetrist for pre and live treatment planning
|
|
|
2005
|
75 |
S1 |
p. S30-
1 p.
|
artikel
|
| 22 |
102 Clear cell adenocarcinoma of the vagina and/or the cervix after diethylstilbestrol (DES) in utero exposure: 35 years later
|
|
|
2005
|
75 |
S1 |
p. S42-
1 p.
|
artikel
|
| 23 |
24 Clinical application of the different size of dose / fraction in brachytherapy of the cervical cancer
|
|
|
2005
|
75 |
S1 |
p. S10-S11
2 p.
|
artikel
|
| 24 |
12 Clinical outcome based on two years biopsy for HDR prostate boost using inverse planning: the Quebec Experience
|
|
|
2005
|
75 |
S1 |
p. S5-
1 p.
|
artikel
|
| 25 |
109 Clinical outcome of re-irradiated patients for isolated vaginal relapse for cervix cancer
|
|
|
2005
|
75 |
S1 |
p. S44-S45
2 p.
|
artikel
|
| 26 |
135 Combination of interstitial HDR-brachytherapy and teletherapy IMRT in organ preserving treatment of patients with T1-T2 N0 oral cavity and mobile tongue cancer
|
|
|
2005
|
75 |
S1 |
p. S53-
1 p.
|
artikel
|
| 27 |
41 Comparing the outcome in patients with locally advanced or recurrent sigmoid/rectum cancer after preoperative radiotherapy + surgery with and without intraoperative HDR brachytherapy (IOBT)
|
|
|
2005
|
75 |
S1 |
p. S19-
1 p.
|
artikel
|
| 28 |
59 Comparison of CT- and radiograph-based post-implant dosimetry for transperineal I-125 prostate brachytherapy using single seeds and a commercial treatment planning software
|
|
|
2005
|
75 |
S1 |
p. S26-S27
2 p.
|
artikel
|
| 29 |
58 Comparison of prostate volumes delineated on pre-implant MRI, pre-implant US and intra-operative US images for planning of permanent prostate implants
|
|
|
2005
|
75 |
S1 |
p. S26-
1 p.
|
artikel
|
| 30 |
149 Correlation of length of interval between pulses in PDR brachytherapy and value of Biologically Equivalent Dose (BED) in Clinical Target Volume (CTV) and surrounded health tissues
|
|
|
2005
|
75 |
S1 |
p. S56-S57
2 p.
|
artikel
|
| 31 |
123 Cosmetic outcome and quality of life after High-Dose-Rate brachytherapy as a boost in breast conservative therapy: patient's and physician's perspectives
|
|
|
2005
|
75 |
S1 |
p. S49-S50
2 p.
|
artikel
|
| 32 |
143 Cs137 LDR afterloading and interventional possibilities in inoperable bile duct tumors
|
|
|
2005
|
75 |
S1 |
p. S55-
1 p.
|
artikel
|
| 33 |
150 CT-based dosimetry in brachytherapy
|
|
|
2005
|
75 |
S1 |
p. S57-
1 p.
|
artikel
|
| 34 |
35 Cystic craniopharyngiomas: Long-term results following intracavitary irradiation with yttrium-90 colloid solution
|
|
|
2005
|
75 |
S1 |
p. S14-
1 p.
|
artikel
|
| 35 |
65 Decreased incidence of urinary retention after prostate brachytherapy: the learning curve of dosimetric constraints
|
|
|
2005
|
75 |
S1 |
p. S29-
1 p.
|
artikel
|
| 36 |
91 Determinants of disease control following iodine-125 permanent seed brachytherapy in low risk prostate cancer
|
|
|
2005
|
75 |
S1 |
p. S38-S39
2 p.
|
artikel
|
| 37 |
66 Dose calculation strategies in brachytherapy
|
|
|
2005
|
75 |
S1 |
p. S30-
1 p.
|
artikel
|
| 38 |
158 Dose field of modified Heyman packing
|
|
|
2005
|
75 |
S1 |
p. S59-
1 p.
|
artikel
|
| 39 |
99 Dose-optimisation for brachytherapy cylinder applicators in high dose rate Ir-192 vaginal vault treatments for endometrial cancer
|
|
|
2005
|
75 |
S1 |
p. S41-
1 p.
|
artikel
|
| 40 |
45 Dose optimization in interstitial brachytherapy of rectal cancer
|
|
|
2005
|
75 |
S1 |
p. S20-
1 p.
|
artikel
|
| 41 |
154 Dose planning with BrachyVision for I-125 episcleral plaque therapy
|
|
|
2005
|
75 |
S1 |
p. S58-
1 p.
|
artikel
|
| 42 |
114 Dose reduction in relation to increased dose rate at MDR/LDR brachytherapy treatments for cancer of the uterine cervix
|
|
|
2005
|
75 |
S1 |
p. S46-
1 p.
|
artikel
|
| 43 |
69 Dose-volume comparative analysis of mLDR interstitial breast implants planned theoretically and with image-based dosimetry systems
|
|
|
2005
|
75 |
S1 |
p. S31-
1 p.
|
artikel
|
| 44 |
22 Dose-volume-effect relations and pattern of response in MRI-based cervical cancer brachytherapy — Comparison between recurred and disease free patients
|
|
|
2005
|
75 |
S1 |
p. S9-S10
2 p.
|
artikel
|
| 45 |
23 Dosimetric comparison between Pulse Dose Rate (PDR) and Low Dose Rate (LDR) brachytherapy (BT) based on 3D-imaging techniques in cervix cancer
|
|
|
2005
|
75 |
S1 |
p. S10-
1 p.
|
artikel
|
| 46 |
101 Dosimetric differences between different endocavitary fractions of HDR-BT in advanced cervical carcinomas
|
|
|
2005
|
75 |
S1 |
p. S42-
1 p.
|
artikel
|
| 47 |
21 Do we need individual MRI based treatment planning for each insertion of cervix cancer brachytherapy? Findings based on 11 patients with 44 individual fractions
|
|
|
2005
|
75 |
S1 |
p. S9-
1 p.
|
artikel
|
| 48 |
122 3D Treatment planning in partial breast irradiation (PBI) with interstitial high dose-rate brachytherapy
|
|
|
2005
|
75 |
S1 |
p. S49-
1 p.
|
artikel
|
| 49 |
63 Early and late rectal toxicity after transperineal interstitial permanent brachytherapy: a multivariate analysis of 600 patients treated by the Institut Curie/Hôpital Cochin/Hôpital Necker Paris group
|
|
|
2005
|
75 |
S1 |
p. S28-
1 p.
|
artikel
|
| 50 |
124 Effect of different fraction schedules on mammalian cell (MDAMB 231) survival using HDR Ir-192 afterloading remote machine and an in-vitro model
|
|
|
2005
|
75 |
S1 |
p. S50-
1 p.
|
artikel
|
| 51 |
71 Elimination of the procedure and dosimetry learning curve in permanent seed implants by the use of advanced technology
|
|
|
2005
|
75 |
S1 |
p. S31-S32
2 p.
|
artikel
|
| 52 |
46 Endovascular brachytherapy for de-novo and recurrent femoropopliteal lesions
|
|
|
2005
|
75 |
S1 |
p. S20-S21
2 p.
|
artikel
|
| 53 |
17 ESTRO brachytherapy survey (PCBE questionnaire): Results in Italy
|
|
|
2005
|
75 |
S1 |
p. S7-
1 p.
|
artikel
|
| 54 |
20 Evaluation of controuring concepts and dose volume parameters of MR based brachytherapy treatment plans for cervix cancer: results and conclusions of the GEC ESTRO GYN working group delineation workshops
|
|
|
2005
|
75 |
S1 |
p. S9-
1 p.
|
artikel
|
| 55 |
29 Exclusive brachytherapy for T1 and T2 squamous cell carcinomas of the velotonsillar area: results in 44 patients
|
|
|
2005
|
75 |
S1 |
p. S12-S13
2 p.
|
artikel
|
| 56 |
48 Existing guidelines for prostate brachytherapy: Criticisms
|
|
|
2005
|
75 |
S1 |
p. S22-
1 p.
|
artikel
|
| 57 |
145 Experience in brachytherapy of locally advanced bronchus /esophago-bronchial cancer patients: conventional and CT-based planning
|
|
|
2005
|
75 |
S1 |
p. S55-S56
2 p.
|
artikel
|
| 58 |
100 Factors impacting on overall survival of patients with cervix cancer
|
|
|
2005
|
75 |
S1 |
p. S41-S42
2 p.
|
artikel
|
| 59 |
125 Fetal radiation dose: a phantom study of potential dose to the uterus at 12 and 24 weeks gestation with accelerated intracavitary partial breast irradiation
|
|
|
2005
|
75 |
S1 |
p. S50-
1 p.
|
artikel
|
| 60 |
34 Fractionated iridium 192 HDR-brachytherapy in skull base tumors
|
|
|
2005
|
75 |
S1 |
p. S14-
1 p.
|
artikel
|
| 61 |
151 From continuous low dose rate to pulsed dose rate brachytherapy: the practical benefits
|
|
|
2005
|
75 |
S1 |
p. S57-
1 p.
|
artikel
|
| 62 |
90 Fusion of pre-implant MRI and intra-operative US images for planning of permanent prostate implants
|
|
|
2005
|
75 |
S1 |
p. S38-
1 p.
|
artikel
|
| 63 |
36 GEC-ESTRO or how to construct Europe a flashback on 17 years of sharing expertise, dedication and joint purpose
|
|
|
2005
|
75 |
S1 |
p. S15-
1 p.
|
artikel
|
| 64 |
111 HDR-AL for cervical carcinoma, MRI based localization of intracavitary applicators
|
|
|
2005
|
75 |
S1 |
p. S45-
1 p.
|
artikel
|
| 65 |
10 HDR brachytherapy boost irradiation in the radiotherapy (RT) of intermediate and high risk localised prostate cancer
|
|
|
2005
|
75 |
S1 |
p. S4-S5
2 p.
|
artikel
|
| 66 |
9 HDR brachytherapy combined with external radiotherapy for localised prostate cancer; 5 year follow-up
|
|
|
2005
|
75 |
S1 |
p. S4-
1 p.
|
artikel
|
| 67 |
152 HDR-brachytherapy to prevent non-malignant obstruction in lung transplant bronchus — update
|
|
|
2005
|
75 |
S1 |
p. S57-S58
2 p.
|
artikel
|
| 68 |
117 HDR dose planning for inoperable endometrial carcinoma with modified Heyman packing technique
|
|
|
2005
|
75 |
S1 |
p. S47-S48
2 p.
|
artikel
|
| 69 |
15 HDR monotherapy for localised prostate cancer
|
|
|
2005
|
75 |
S1 |
p. S6-
1 p.
|
artikel
|
| 70 |
62 Health related quality of life following brachytherapy: back to normal in 9 months
|
|
|
2005
|
75 |
S1 |
p. S27-S28
2 p.
|
artikel
|
| 71 |
95 Health-related quality of life (HRQOL) after permanent interstitial brachytherapy for prostate cancer — a correlation with postimplant CT scan parameters
|
|
|
2005
|
75 |
S1 |
p. S40-
1 p.
|
artikel
|
| 72 |
142 Helmet mould based surface brachytherapy for homogeneous scalp treatment — case report
|
|
|
2005
|
75 |
S1 |
p. S55-
1 p.
|
artikel
|
| 73 |
136 High dose rate brachytherapy and cervical dissection on head and neck cancer
|
|
|
2005
|
75 |
S1 |
p. S53-
1 p.
|
artikel
|
| 74 |
138 High dose rate brachytherapy and chemoradiation as salvage for recurrent nasopharyngeal cancer
|
|
|
2005
|
75 |
S1 |
p. S54-
1 p.
|
artikel
|
| 75 |
93 High dose rate brachytherapy for elderly patients
|
|
|
2005
|
75 |
S1 |
p. S39-
1 p.
|
artikel
|
| 76 |
105 High dose rate brachytherapy for gynaecological cancers: our experience
|
|
|
2005
|
75 |
S1 |
p. S43-
1 p.
|
artikel
|
| 77 |
56 How to manage side effects in brachytherapy: gynaecological side effects
|
|
|
2005
|
75 |
S1 |
p. S25-
1 p.
|
artikel
|
| 78 |
139 Image fusion guided 125 iodine interstitial irradiation of gliomas
|
|
|
2005
|
75 |
S1 |
p. S54-
1 p.
|
artikel
|
| 79 |
7 Incidence of fat necrosis following whole breast radiotherapy versus partial breast irradiation: results of the Budapest partial breast irradiation trial
|
|
|
2005
|
75 |
S1 |
p. S3-
1 p.
|
artikel
|
| 80 |
133 Influence of optimization on interstitial breast brachytherapy
|
|
|
2005
|
75 |
S1 |
p. S52-
1 p.
|
artikel
|
| 81 |
155 Initial experience with Therasight ocular brachytherapy system for treatment of ARMD
|
|
|
2005
|
75 |
S1 |
p. S58-S59
2 p.
|
artikel
|
| 82 |
126 Initial results of a prospective clinical trial of accelerated partial breast irradiation (APBI) with high dose rate brachytherapy (HDRB) in patients with breast cancer (BC)
|
|
|
2005
|
75 |
S1 |
p. S50-S51
2 p.
|
artikel
|
| 83 |
26 Initial results of a prospective phase I/II trial of perioperative high dose rate brachytherapy (PHDRB) in locally advanced or recurrent gynaecological cancer (GYNa/r)
|
|
|
2005
|
75 |
S1 |
p. S11-S12
2 p.
|
artikel
|
| 84 |
107 Inter-fraction movements of brachytherapy cylinder applicators during high dose rate Ir-192 vaginal vault treatments for endometrial cancer
|
|
|
2005
|
75 |
S1 |
p. S44-
1 p.
|
artikel
|
| 85 |
137 Interstitial brachytherapy in the treatment of relapse of previously irradiated head and neck tumours
|
|
|
2005
|
75 |
S1 |
p. S53-S54
2 p.
|
artikel
|
| 86 |
127 Interstitial high-dose-rate brachytherapy as a method of boost in breast conservative therapy for patients with close to positive margins
|
|
|
2005
|
75 |
S1 |
p. S51-
1 p.
|
artikel
|
| 87 |
44 Interstitial PDR brachytherapy in locally inoperable primary or recurrent rectal cancer
|
|
|
2005
|
75 |
S1 |
p. S20-
1 p.
|
artikel
|
| 88 |
144 Intracatheter high-dose-rate brachytherapy for biliary obstruction by secondary malignant tumors
|
|
|
2005
|
75 |
S1 |
p. S55-
1 p.
|
artikel
|
| 89 |
115 Intra-fraction variation in doses to OAR in intracavitary HDR brachytherapy for cervical cancer
|
|
|
2005
|
75 |
S1 |
p. S46-S47
2 p.
|
artikel
|
| 90 |
73 Intraoperative and interactive planning for permanent prostate brachytherapy: dosimetric and clinical results
|
|
|
2005
|
75 |
S1 |
p. S33-
1 p.
|
artikel
|
| 91 |
28 Intraoperative single fraction high dose rate brachytherapy for head and neck cancers
|
|
|
2005
|
75 |
S1 |
p. S12-
1 p.
|
artikel
|
| 92 |
70 In vivo dosimetry used to describe the geometric relation between applicator and rectal diodes during pulsed dose rate brachytherapy
|
|
|
2005
|
75 |
S1 |
p. S31-
1 p.
|
artikel
|
| 93 |
3 Is it possible to perform a conservative treatment for patients with positive or close surgical margins after conservative surgery in breast cancer?
|
|
|
2005
|
75 |
S1 |
p. S2-
1 p.
|
artikel
|
| 94 |
43 Late results of function preservation by intensity modulated and transrectal ultrasound guided interstitial HDR brachytherapy (IMBT) boost with complementary external beam irradiation in alal cancer
|
|
|
2005
|
75 |
S1 |
p. S19-S20
2 p.
|
artikel
|
| 95 |
146 LDR Cs137 afterloading irradiation and long term results for lumen restricting esophageal tumors
|
|
|
2005
|
75 |
S1 |
p. S56-
1 p.
|
artikel
|
| 96 |
108 LDR & PDR gynecological brachytherapy at the Institute of Oncology in Ljubljana, Slovenia — the need of applying the flexible rectal probe
|
|
|
2005
|
75 |
S1 |
p. S44-
1 p.
|
artikel
|
| 97 |
30 Longitudinal changes and factors influencing quality of life in long-term survivors of Tonsillar Fossa and/or soft palate tumors treated with brachytherapy or surgery
|
|
|
2005
|
75 |
S1 |
p. S13-
1 p.
|
artikel
|
| 98 |
83 Low dose measured by TLD in the anus during HDR brachytherapy for prostate cancer
|
|
|
2005
|
75 |
S1 |
p. S36-
1 p.
|
artikel
|
| 99 |
128 Lowering the risk of pneumonitis: a dose volume histogram analysis of the ipsilateral lung with accelerated intracavitary partial breast irradiation
|
|
|
2005
|
75 |
S1 |
p. S51-
1 p.
|
artikel
|
| 100 |
55 Management of radiation-induced bowel damage
|
|
|
2005
|
75 |
S1 |
p. S25-
1 p.
|
artikel
|
| 101 |
13 3-Months acute toxicity for Pulsed Dose-Rate prostate brachytherapy boost
|
|
|
2005
|
75 |
S1 |
p. S5-S6
2 p.
|
artikel
|
| 102 |
75 Morbidity after transperineal permanent interstitial seedimplantation (TPSI) in 275 patient with Low risk“ prostate cancer
|
|
|
2005
|
75 |
S1 |
p. S33-
1 p.
|
artikel
|
| 103 |
60 Movement of strands during one day following implantation in prostate brachytherapy
|
|
|
2005
|
75 |
S1 |
p. S27-
1 p.
|
artikel
|
| 104 |
25 MRI assisted 3D treatment planning in intracavitary and interstitial cervix cancer HDR brachytherapy and its impact on local tumour control: Vienna experience in 145 patients treated from 1998–2003
|
|
|
2005
|
75 |
S1 |
p. S11-
1 p.
|
artikel
|
| 105 |
27 MRI-guided treatment of cervical cancer patients; comparing brachytherapy with an IMRT-boost technique
|
|
|
2005
|
75 |
S1 |
p. S12-
1 p.
|
artikel
|
| 106 |
87 Objective comparison of RAPID strand and free selectSeeds loading for permanent prostate implants using an inverse planning approach
|
|
|
2005
|
75 |
S1 |
p. S37-
1 p.
|
artikel
|
| 107 |
132 Optimization and clinical acceptance of interstitial brachytherapy breast implants
|
|
|
2005
|
75 |
S1 |
p. S52-
1 p.
|
artikel
|
| 108 |
37 Optimization in interstitial brachytherapy
|
|
|
2005
|
75 |
S1 |
p. S16-
1 p.
|
artikel
|
| 109 |
110 Outcome modalities of patients with cervix carcinoma with macroscopic residual disease after concomitant chemoradiotherapy and brachytherapy
|
|
|
2005
|
75 |
S1 |
p. S45-
1 p.
|
artikel
|
| 110 |
16 Overview of brachytherapy resources in Europe: a survey of Patterns of Care study for Brachytherapy in Europe (PCBE)
|
|
|
2005
|
75 |
S1 |
p. S7-
1 p.
|
artikel
|
| 111 |
129 Partial breast irradiation with interstitial high dose-rate brachytherapy: preliminary results of a phase I-II prospective study
|
|
|
2005
|
75 |
S1 |
p. S51-S52
2 p.
|
artikel
|
| 112 |
6 Partial breast irradiation with 192-iridium implants after breast conserving surgery: updated results of the German-Austrianphase II trial
|
|
|
2005
|
75 |
S1 |
p. S3-
1 p.
|
artikel
|
| 113 |
79 Pathologic features of the prostate and seminal vesicles from eleven prostate cancer patients undergoing salvage surgery: high volume cancer with seminal vesicle involvement is common
|
|
|
2005
|
75 |
S1 |
p. S35-
1 p.
|
artikel
|
| 114 |
103 Patterns of complications due to HDR intracavitary brachytherapy in cervical cancer patients assessment of potential risk factors
|
|
|
2005
|
75 |
S1 |
p. S42-S43
2 p.
|
artikel
|
| 115 |
8 Permanent breast 103Pd seed implant (PBSI) as adjuvant partial breast irradiation
|
|
|
2005
|
75 |
S1 |
p. S4-
1 p.
|
artikel
|
| 116 |
97 Permanent implantation of the prostate with Pd-103 and J 125 seeds - 5 years of experience
|
|
|
2005
|
75 |
S1 |
p. S40-S41
2 p.
|
artikel
|
| 117 |
57 Permanent prostate implant using high activity seeds and inverse planning algorithm: outcome and toxicity from the first Canadian Program
|
|
|
2005
|
75 |
S1 |
p. S26-
1 p.
|
artikel
|
| 118 |
74 Pilot study on three-dimensional (3D) real time conformal brachytherapy for prostate cancer. Preliminary report of feasibility and early treatment results
|
|
|
2005
|
75 |
S1 |
p. S33-
1 p.
|
artikel
|
| 119 |
153 Possible methods to determine dose modification factor in brachytherapy for the estimation of the risk of late effects of normal tissues
|
|
|
2005
|
75 |
S1 |
p. S58-
1 p.
|
artikel
|
| 120 |
89 Preliminary results of a prospective clinical trial of high dose rate brachytherapy (HDR) in unfavorable prostate cancer
|
|
|
2005
|
75 |
S1 |
p. S38-
1 p.
|
artikel
|
| 121 |
147 Proof of concept of novel 32P brachytherapy device in hepatocellular carcinoma (HCC) in man
|
|
|
2005
|
75 |
S1 |
p. S56-
1 p.
|
artikel
|
| 122 |
77 Prostate cancer brachytherapy; from Variseed system 6.7 to Variseed 7.0: a comparative study on 656 patients
|
|
|
2005
|
75 |
S1 |
p. S34-
1 p.
|
artikel
|
| 123 |
84 Prostate displacement kit: possibilities to reduce the radiation dose to the rectum during HDR brachytherapy
|
|
|
2005
|
75 |
S1 |
p. S36-
1 p.
|
artikel
|
| 124 |
54 Prostate side effects
|
|
|
2005
|
75 |
S1 |
p. S25-
1 p.
|
artikel
|
| 125 |
86 PSA bounce following prostate brachytherapy: can you predict it?
|
|
|
2005
|
75 |
S1 |
p. S37-
1 p.
|
artikel
|
| 126 |
76 PSA bouncing after permanent implant prostate brachytherapy: a study of 295 patients with a three-years follow-up
|
|
|
2005
|
75 |
S1 |
p. S33-S34
2 p.
|
artikel
|
| 127 |
61 PSA nadir ≤4ng/ml within 4 months after external radiotherapy and brachytherapy of prostate cancer as a new indicator for outcome
|
|
|
2005
|
75 |
S1 |
p. S27-
1 p.
|
artikel
|
| 128 |
85 PSA relapse free survival following prostate brachytherapy in intermediate and high risk disease
|
|
|
2005
|
75 |
S1 |
p. S36-S37
2 p.
|
artikel
|
| 129 |
141 Pulsed-dose-rate brachytherapy in treatment of malignant glioma recurrences
|
|
|
2005
|
75 |
S1 |
p. S54-S55
2 p.
|
artikel
|
| 130 |
131 Quality assessment of image-based treatment planning of interstitial brachytherapy breast implants
|
|
|
2005
|
75 |
S1 |
p. S52-
1 p.
|
artikel
|
| 131 |
121 Radical radiotherapy (RT) incorporating high-dose-rate (HDR) brachytherapy for cervical cancer — long-term results from a Single Centre in Singapore
|
|
|
2005
|
75 |
S1 |
p. S49-
1 p.
|
artikel
|
| 132 |
157 Radiobiological criteria for the transfer of LDR protocols into equivalent PDR protocols
|
|
|
2005
|
75 |
S1 |
p. S59-
1 p.
|
artikel
|
| 133 |
113 Radiobiological treatment planning for sectional image guided HDR brachytherapy of cervical carcinoma
|
|
|
2005
|
75 |
S1 |
p. S46-
1 p.
|
artikel
|
| 134 |
51 Recommendations of the Braphyqs Prostate Sub-Group: Summary and directions for new recommendations
|
|
|
2005
|
75 |
S1 |
p. S23-
1 p.
|
artikel
|
| 135 |
49 Recommendations of the Braphyqs Prostate Sub-Group, the clinical part of the questionnaire
|
|
|
2005
|
75 |
S1 |
p. S22-S23
2 p.
|
artikel
|
| 136 |
50 Recommendations of the Braphyqs Prostate Sub-Group, the physics part of the questionnaire
|
|
|
2005
|
75 |
S1 |
p. S23-
1 p.
|
artikel
|
| 137 |
19 Results of the patterns of care for brachytherapy in Europe questionnaire in Hungary
|
|
|
2005
|
75 |
S1 |
p. S8-
1 p.
|
artikel
|
| 138 |
18 Results of the PCBE questionnaire-2002 in Belgium
|
|
|
2005
|
75 |
S1 |
p. S7-S8
2 p.
|
artikel
|
| 139 |
112 Salvage treatment with high-dose rate brachytherapy for isolated vaginal endometrial cancer recurrence
|
|
|
2005
|
75 |
S1 |
p. S45-S46
2 p.
|
artikel
|
| 140 |
98 Sigmoid colon an unexpected organ at risk in brachytherapy for cervix cancer
|
|
|
2005
|
75 |
S1 |
p. S41-
1 p.
|
artikel
|
| 141 |
118 Simultaneous radiochemotherapy & brachytherapy for advanced cervical cancer
|
|
|
2005
|
75 |
S1 |
p. S48-
1 p.
|
artikel
|
| 142 |
5 Single plane implants in the high dose rate boost irradiation of early breast cancer. A critical view
|
|
|
2005
|
75 |
S1 |
p. S2-S3
2 p.
|
artikel
|
| 143 |
80 Strategies for prostate treatments at Centre René Huguenin, Saint Cloud, France
|
|
|
2005
|
75 |
S1 |
p. S35-
1 p.
|
artikel
|
| 144 |
156 Technical feasibility of pulsed-dose-rate brachytherapy
|
|
|
2005
|
75 |
S1 |
p. S59-
1 p.
|
artikel
|
| 145 |
120 The advantage of DMRI based intracavitary brachytherapy for cervical cancer
|
|
|
2005
|
75 |
S1 |
p. S48-S49
2 p.
|
artikel
|
| 146 |
160 The development of special applicators for brachytherapy at the Institute of oncology, Ljubljana, Slovenia
|
|
|
2005
|
75 |
S1 |
p. S60-
1 p.
|
artikel
|
| 147 |
140 The possible role of interstitial HDR AL boost irradiation on survival following external beam radiotherapy in selected glioblastoma patients
|
|
|
2005
|
75 |
S1 |
p. S54-
1 p.
|
artikel
|
| 148 |
31 The role of quality indices for the development of necrosis after interstitial PDR-brachytherapy of head and neck tumours
|
|
|
2005
|
75 |
S1 |
p. S13-
1 p.
|
artikel
|
| 149 |
159 The use of a non-isocentric C-arm as brachytherapy localiser
|
|
|
2005
|
75 |
S1 |
p. S59-S60
2 p.
|
artikel
|
| 150 |
52 The use of phantoms for quality assurance in the postplanning procedure of permanent seed implants
|
|
|
2005
|
75 |
S1 |
p. S23-S24
2 p.
|
artikel
|
| 151 |
68 Three dimensional CT based treatment planning for intracavitary brachytherapy of the cervix — results of a pilot study
|
|
|
2005
|
75 |
S1 |
p. S30-S31
2 p.
|
artikel
|
| 152 |
81 Transperineal I-125 implants for early prostate cancer: Rambam Medical Center, Israel
|
|
|
2005
|
75 |
S1 |
p. S35-S36
2 p.
|
artikel
|
| 153 |
78 Trans-rectal ultrasound and fluoroscopic guided iodine-125 transperineal interstitial permanent prostate brachytherapy monotherapy with CT-based post-implant dosimetry: clinical and dosimetric outcomes
|
|
|
2005
|
75 |
S1 |
p. S34-S35
2 p.
|
artikel
|
| 154 |
106 Treatment related factors affecting early toxicity and cosmetic outcome following mammosite brachytherapy — A single Institution's Clinical Experience
|
|
|
2005
|
75 |
S1 |
p. S43-S44
2 p.
|
artikel
|
| 155 |
92 Using a surrogate urethra in prostate HDR brachytherapy is not an option
|
|
|
2005
|
75 |
S1 |
p. S39-
1 p.
|
artikel
|
| 156 |
130 Validation of a simple cosmetic rating scale to assess aesthetic outcome following interstitial high-dose-rate brachytherapy in early breast cancer patients: Notre-Dame brachytherapy cosmetic scale
|
|
|
2005
|
75 |
S1 |
p. S52-
1 p.
|
artikel
|
| 157 |
104 Virtual 3-D simulation and pre-planning of interstitial gynaecological brachytherapy
|
|
|
2005
|
75 |
S1 |
p. S43-
1 p.
|
artikel
|
| 158 |
82 What have we learned in the first two years about I-125 prostate brachytherapy?
|
|
|
2005
|
75 |
S1 |
p. S36-
1 p.
|
artikel
|
| 159 |
1 What kind of equipment do we need in gynaccological brachytherapy? Clinical, technical and economical aspects for standard and new techniques
|
|
|
2005
|
75 |
S1 |
p. S1-
1 p.
|
artikel
|
| 160 |
4 5 year cosmetic results evaluation of 300 disease free patients treated conservatively with interstitial brachytherapy as part of treatment for breast cancer
|
|
|
2005
|
75 |
S1 |
p. S2-
1 p.
|
artikel
|
| 161 |
2 20 years experience on external beam radiotherapy and Interstitial HDR 192-iridium implantation in breast cancer Patients — a retrospective analysis on 784 patients
|
|
|
2005
|
75 |
S1 |
p. S2-
1 p.
|
artikel
|
Tijdschrift beschrijving